Chris IR Gill

Dr. Chris IR Gill

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 November 2018 in Natural Product Reports
Verified
Journal Article
Closed access
PDF file
Pedro MenaPedro Mena
Pedro Mena
Letizia BrescianiLetizia Bresciani
Letizia Bresciani
NBNicoletta Brindani
Nicoletta Brindani
ILIziar Ludwig
Iziar Ludwig
María Gema Pereira CaroMaría Gema Pereira Caro
María Gema Pereira Caro
DRDaniele Del Rio
Daniele Del Rio
Covering: 1958 to June 2018 Phenyl-γ-valerolactones (PVLs) and their related phenylvaleric acids (PVAs) are the main metabolites of flavan-3-ols, the major class of flavonoids in the human diet. Despite their presumed importance, these gut microbiota-derived compounds have, to date, in terms of biological activity, been considered subordinate to their parent dietary compounds, the flavan-3-ol monomers and proanthocyanidins. In this review, the role and prospects of PVLs and PVAs as key metabolites in the understanding of the health features of flavan-3-ols have been critically assessed. Among the topics covered, are proposals for a standardised nomenclature for PVLs and PVAs. The formation, bioavailability and pharmacokinetics of PVLs and PVAs from different types of flavan-3-ols are discussed, taking into account in vitro and animal studies, as well as inter-individual differences and the existence of putative flavan-3-ol metabotypes. Synthetic strategies used for the preparation of PVLs are considered and the methodologies for their identification and quantification assessed. Metabolomic approaches unravelling the role of PVLs and PVAs as biomarkers of intake are also described. Finally, the biological activity of these microbial catabolites in different experimental models is summarised. Knowledge gaps and future research are considered in this key area of dietary (poly)phenol research.

1 February 2007 in The American Journal of Clinical Nutrition
Verified
Journal Article
Open access
PDF file
CGChris IR Gill
Chris IR Gill
SHSumanto Haldar
Sumanto Haldar
LBLindsay A Boyd
Lindsay A Boyd
RBRichard Bennett
Richard Bennett
JWJoy Whiteford
Joy Whiteford
IRIan R Rowland
Ian R Rowland
Background: Cruciferous vegetable (CV) consumption is associated with a reduced risk of several cancers in epidemiologic studies. Objective: The aim of this study was to determine the effects of watercress (a CV) supplementation on biomarkers related to cancer risk in healthy adults. Design: A single-blind, randomized, crossover study was conducted in 30 men and 30 women (30 smokers and 30 nonsmokers) with a mean age of 33 y (range: 19–55 y). The subjects were fed 85 g raw watercress daily for 8 wk in addition to their habitual diet. The effect of supplementation was measured on a range of endpoints, including DNA damage in lymphocytes (with the comet assay), activity of detoxifying enzymes (glutathione peroxidase and superoxide dismutase) in erythrocytes, plasma antioxidants (retinol, ascorbic acid, α-tocopherol, lutein, and β-carotene), plasma total antioxidant status with the use of the ferric reducing ability of plasma assay, and plasma lipid profile. Results: Watercress supplementation (active compared with control phase) was associated with reductions in basal DNA damage (by 17%; P = 0.03), in basal plus oxidative purine DNA damage (by 23.9%; P = 0.002), and in basal DNA damage in response to ex vivo hydrogen peroxide challenge (by 9.4%; P = 0.07). Beneficial changes seen after watercress intervention were greater and more significant in smokers than in nonsmokers. Plasma lutein and β-carotene increased significantly by 100% and 33% (P < 0.001), respectively, after watercress supplementation. Conclusion: The results support the theory that consumption of watercress can be linked to a reduced risk of cancer via decreased damage to DNA and possible modulation of antioxidant status by increasing carotenoid concentrations.

2 August 2005 in International Journal of Cancer
Verified
Journal Article
Open access
PDF file
CGChris IR Gill
Chris IR Gill
ABAdele Boyd
Adele Boyd
EMEmily McDermott
Emily McDermott
MMMark Mccann
Mark Mccann
MSMaurizio Servili
Maurizio Servili
IRIan Rowland
Ian Rowland
The traditional Mediterranean diet is thought to represent a healthy lifestyle; especially given the incidence of several cancers including colorectal cancer is lower in Mediterranean countries compared to Northern Europe. Olive oil, a central component of the Mediterranean diet, is believed to beneficially affect numerous biological processes. We used phenols extracted from virgin olive oil on a series of in vitro systems that model important stages of colon carcinogenesis. The effect the extract on DNA damage induced by hydrogen peroxide was measured in HT29 cells using single cell microgel-electrophoresis. A significant anti-genotoxic linear trend (p = 0.011) was observed when HT29 cells were pre-incubated with olive oil phenols (0, 5, 10, 25, 50, 75, 100 μg/ml) for 24 hr, then challenged with hydrogen peroxide. The olive oil phenols (50, 100 μg/ml) significantly (p = 0.004, p = 0.002) improved barrier function of CACO2 cells after 48 hr as measured by trans-epithelial resistance. Significant inhibition of HT115 invasion (p < 0.01) was observed at olive oil phenols concentrations of 25, 50, 75, 100 μg/ml using the matrigel invasion assay. No effect was observed on HT115 viability over the concentration range 0, 25, 50 75, 100 μg/ml after 24 hr, although 75 and 100 μg/ml olive oil phenols significantly inhibited HT115 cell attachment (p = 0.011, p = 0.006). Olive oil phenols had no significant effect on metastasis-related gene expression in HT115 cells. We have demonstrated that phenols extracted from virgin olive oil are capable of inhibiting several stages in colon carcinogenesis in vitro.

1 January 2007 in Journal of Carcinogenesis
Verified
Journal Article
Open access
PDF file
ECEmma M Coates
Emma M Coates
GPGina Popa
Gina Popa
CGChris IR Gill
Chris IR Gill
MMMark Mccann
Mark Mccann
GMGordon J McDougall
Gordon J McDougall
IRIan Rowland
Ian Rowland
J Carcinog, Official publication of Carcenogenesis Press

30 October 2014 in BioFactors
Verified
Journal Article
Closed access
PDF file
EBEmma M. Brown
Emma M. Brown
SNSonja Nitecki
Sonja Nitecki
María Gema Pereira CaroMaría Gema Pereira Caro
María Gema Pereira Caro
GMGordon J. McDougall
Gordon J. McDougall
DSDerek Stewart
Derek Stewart
CGChris IR Gill
Chris IR Gill

21 November 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
EBEmma M. Brown
Emma M. Brown
GMGordon J. McDougall
Gordon J. McDougall
DSDerek Stewart
Derek Stewart
María Gema Pereira CaroMaría Gema Pereira Caro
María Gema Pereira Caro
RBRocio González Barrio
Rocio González Barrio
CGChris IR Gill
Chris IR Gill
Fruit and vegetable consumption is associated at the population level with a protective effect against colorectal cancer. Phenolic compounds, especially abundant in berries, are of interest due to their putative anticancer activity. After consumption, however, phenolic compounds are subject to digestive conditions within the gastrointestinal tract that alter their structures and potentially their function. However, the majority of phenolic compounds are not efficiently absorbed in the small intestine and a substantial portion pass into the colon. We characterized berry extracts (raspberries, strawberries, blackcurrants) produced by in vitro-simulated upper intestinal tract digestion and subsequent fecal fermentation. These extracts and selected individual colonic metabolites were then evaluated for their putative anticancer activities using in vitro models of colorectal cancer, representing the key stages of initiation, promotion and invasion. Over a physiologically-relevant dose range (0–50 µg/ml gallic acid equivalents), the digested and fermented extracts demonstrated significant anti-genotoxic, anti-mutagenic and anti-invasive activity on colonocytes. This work indicates that phenolic compounds from berries undergo considerable structural modifications during their passage through the gastrointestinal tract but their breakdown products and metabolites retain biological activity and can modulate cellular processes associated with colon cancer.